ICON Announces Acquisition of PRA Health Sciences

Healthcare intelligence company ICON has announced its plans to acquire PRA Health. The move is expected to provide immense value for customers, employees, shareholders, and society. ICON aims to accelerate drug development using new technologies as it seeks to address unmet healthcare needs.

“The combined company will create a new paradigm for accelerating clinical research and bringing new medicines to market. The COVID-19 pandemic has highlighted the need for rapid development of vaccines and medicines that threaten populations, and there continue to remain many illnesses for which medical treatments are needed.” Read more here.

(Source: ICON, 7/1/21)